Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$425M |
| 2 |
Texas Instruments
TXN
|
+$403M |
| 3 |
AbbVie
ABBV
|
+$296M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$251M |
| 5 |
Meta Platforms (Facebook)
META
|
+$245M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$948M |
| 2 |
Gilead Sciences
GILD
|
+$701M |
| 3 |
SLB Ltd
SLB
|
+$520M |
| 4 |
Qualcomm
QCOM
|
+$273M |
| 5 |
AT&T
T
|
+$213M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 15.29% |
| 3 | Financials | 12.28% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Kura Oncology
KURA
$946M
| $1.49M | ﹤0.01% |
149,828
+4,919
| +3% | +$56.3K |
|
2677
BCB Bancorp
BCBP
$162M
| $1.49M | ﹤0.01% |
139,901
-3,820
| -3% | -$46.9K |
|
|
ZEUS
2678
DELISTED
Olympic Steel
ZEUS
| $1.49M | ﹤0.01% |
143,868
+10,030
| +7% | +$135K |
|
|
CCRD
2679
DELISTED
CoreCard
CCRD
| $1.49M | ﹤0.01% |
43,744
-77
| -0.2% | -$2.88K |
|
|
ATRS
2680
DELISTED
Antares Pharma, Inc.
ATRS
| $1.49M | ﹤0.01% |
629,369
-176,850
| -22% | -$602K |
|
2681
iShares Expanded Tech Sector ETF
IGM
$10.8B
| $1.48M | ﹤0.01% |
42,060
-594
| -1% | -$23.8K |
|
2682
iShares MSCI Poland ETF
EPOL
$822M
| $1.48M | ﹤0.01% |
107,867
+4,301
| +4% | +$78.8K |
|
2683
AnaptysBio
ANAB
$1.7B
| $1.48M | ﹤0.01% |
104,665
+4,270
| +4% | +$64.8K |
|
2684
Chewy
CHWY
$9.15B
| $1.48M | ﹤0.01% |
39,356
+4,201
| +12% | +$123K |
|
2685
Viking Therapeutics
VKTX
$3.85B
| $1.48M | ﹤0.01% |
315,168
+3,875
| +1% | +$23.8K |
|
|
GTHX
2686
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.47M | ﹤0.01% |
133,726
-575
| -0.4% | -$10.7K |
|
|
LL
2687
DELISTED
LL Flooring Holdings, Inc.
LL
| $1.47M | ﹤0.01% |
314,001
-15,436
| -5% | -$121K |
|
2688
Nathan's Famous
NATH
$397M
| $1.47M | ﹤0.01% |
24,092
-699
| -3% | -$45K |
|
|
CLCT
2689
DELISTED
Collectors Universe
CLCT
| $1.47M | ﹤0.01% |
93,566
-3,811
| -4% | -$85.2K |
|
2690
Invesco DB US Dollar Index Bullish Fund
UUP
$414M
| $1.46M | ﹤0.01% |
54,504
-2,999
| -5% | -$79.8K |
|
2691
Lexicon Pharmaceuticals
LXRX
$1.03B
| $1.46M | ﹤0.01% |
746,265
-48,611
| -6% | -$145K |
|
2692
Willis Lease Finance
WLFC
$1.19B
| $1.45M | ﹤0.01% |
164,001
-7,461
| -4% | -$123K |
|
2693
Vanguard Consumer Staples ETF
VDC
$8.04B
| $1.45M | ﹤0.01% |
10,498
-4,792
| -31% | -$739K |
|
2694
Puma Biotechnology
PBYI
$449M
| $1.44M | ﹤0.01% |
170,597
-2,860
| -2% | -$27.8K |
|
|
BRSP
2695
BrightSpire Capital
BRSP
$633M
| $1.44M | ﹤0.01% |
365,019
-2,920
| -0.8% | -$32K |
|
|
PDLI
2696
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.44M | ﹤0.01% |
509,563
-47,797
| -9% | -$154K |
|
2697
Global Water Resources
GWRS
$253M
| $1.43M | ﹤0.01% |
140,666
-2,063
| -1% | -$25.3K |
|
2698
iShares Micro-Cap ETF
IWC
$1.51B
| $1.43M | ﹤0.01% |
21,336
+904
| +4% | +$79.8K |
|
2699
Amalgamated Financial
AMAL
$1.52B
| $1.43M | ﹤0.01% |
131,922
-7,911
| -6% | -$127K |
|
2700
AMES National
ATLO
$283M
| $1.43M | ﹤0.01% |
69,700
-207
| -0.3% | -$5.22K |
|
Similar funds
Bank of New York Mellon's Q1 2020 Portfolio in Review
As of Q1 2020, Bank of New York Mellon held 4,289 positions worth $302B, down 22% from $388B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q1 2020 filing shows 113 new, 1,571 increased, 2,175 reduced and 192 closed positions. Its largest new stake was 1Life Healthcare: 2,014,468 shares worth $36.6M. The largest sale was Starbucks, an estimated $948M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q1 2020 buy was 1Life Healthcare: 2,014,468 shares worth $36.6M.
- Bank of New York Mellon added most to Illumina in Q1 2020, an estimated $425M increase.
- Bank of New York Mellon's biggest Q1 2020 reduction was Starbucks, cutting an estimated $948M.
- Bank of New York Mellon fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $170M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $302B portfolio in Q1 2020.
- Bank of New York Mellon opened 113 new positions and closed 192 in Q1 2020.
- Bank of New York Mellon's portfolio value fell 22% quarter-over-quarter to $302B.
Based on Bank of New York Mellon's 13F filing for Q1 2020, filed 6 May 2020.